pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Lutrate Depot
drug
save

leuprolide acetate SR

Marketedupdated 3mo ago
by InvaGen Pharmaceuticals Inc
Approved
community read0 votes

🐶 often sniffed alongside

top 7
  • tagApproval246 co-mentions · 123 sources
  • drugLEUPROLIDE ACETATE204 co-mentions · 123 sources
  • drugleuprolide acetate PR164 co-mentions · 123 sources
  • drugFensolvi129 co-mentions · 123 sources
  • drugFENSOLVI KIT129 co-mentions · 123 sources
  • drugleuprolide acetate ER123 co-mentions · 123 sources
  • tagEndocrinology & Metabolism75 co-mentions · 75 sources

all catalysts(0)

nothing on the calendar yet

Trials studying leuprolide acetate SR

  • phase2A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Studyrecruitingn=900
  • phase1Neo-DAB: Darolutamide and Abemaciclib in Prostate Canceractive not recruitingn=9
  • phase2Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Canceractive not recruitingn=28
  • phase2Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADTcompletedn=23
  • phase1Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Canceractive not recruitingn=25
  • phase2Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinomarecruitingn=37
  • phase3Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetatecompletedn=387
  • phase2Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patientsrecruitingn=124
more trials →

News(0)

no news has mentioned this drug yet

brand
Lutrate Depot
generic
leuprolide acetate
indication
Prostate Cancer
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 18m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?